Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal
Recent progress in the development of molecular cancer therapeutics has revealed new
types of antitumor drugs, such as Herceptin, Gleevec, and Iressa, as potent therapeutics for
specific tumors. Our work has focused on molecular cancer therapeutics, mainly in the areas
of drug resistance, apoptosis and apoptosis resistance, and survival‐signaling, which is
related to drug resistance. In this review, we describe our research on molecular cancer
therapeutics, including molecular mechanisms and therapeutic approaches. Resistance to …
types of antitumor drugs, such as Herceptin, Gleevec, and Iressa, as potent therapeutics for
specific tumors. Our work has focused on molecular cancer therapeutics, mainly in the areas
of drug resistance, apoptosis and apoptosis resistance, and survival‐signaling, which is
related to drug resistance. In this review, we describe our research on molecular cancer
therapeutics, including molecular mechanisms and therapeutic approaches. Resistance to …
[引用][C] MOLECULAR TARGETING THERAPY OF CANCER: DRUG RESISTANCE, APOPTOSIS AND SURVIVAL SIGNAL
T Takashi, N Mikihiko, F Naoya, M Tetsuo… - Gann monograph on …, 2004 - cir.nii.ac.jp
… Institute of Molecular and Cellular Biosciences, The University of Tokyo … Institute of
Molecular and Cellular Biosciences, The University of Tokyo … Institute of Molecular and
Cellular Biosciences, The University of Tokyo …
Molecular and Cellular Biosciences, The University of Tokyo … Institute of Molecular and
Cellular Biosciences, The University of Tokyo …
以上显示的是最相近的搜索结果。 查看全部搜索结果